Last Updated: November 10, 2026

Micro Labs Company Profile

« Back to Dashboard

What is the competitive landscape for MICRO LABS

MICRO LABS has one hundred and twelve approved drugs.

There are nine tentative approvals on MICRO LABS drugs.

Summary for Micro Labs

US Patents:	0
Tradenames:	102
Ingredients:	102
NDAs:	112
Patent Litigation for Micro Labs:	See patent lawsuits for Micro Labs
PTAB Cases with Micro Labs as petitioner:	See PTAB cases with Micro Labs as petitioner

Drugs and US Patents for Micro Labs

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Micro Labs	GLIMEPIRIDE	glimepiride	TABLET;ORAL	091220-001	Jun 29, 2012	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Micro Labs	DAPAGLIFLOZIN	dapagliflozin	TABLET;ORAL	211467-002	Apr 6, 2026	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Micro Labs	OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE	amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil	TABLET;ORAL	207437-004	Nov 24, 2025	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Micro Labs	PIROXICAM	piroxicam	CAPSULE;ORAL	206152-001	Dec 29, 2017	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Micro Labs	CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE	amitriptyline hydrochloride; chlordiazepoxide	TABLET;ORAL	211925-002	Feb 2, 2022		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.